The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York September 8, 2025: FDA launches an import alert listing safe GLP 1 manufacturers Partnership for Safe Medicines FDA takes first step in possible reversal of ban on some peptides The Washington Post September 8, 2025: FDA launches an import alert listing safe GLP 1 manufacturers Partnership for Safe Medicines